vs
Penumbra Inc（PEN）与Regency Centers（REG）财务数据对比。点击上方公司名可切换其他公司
Regency Centers的季度营收约是Penumbra Inc的1.0倍（$404.2M vs $385.4M），Regency Centers净利率更高（50.1% vs 12.3%，领先37.8%），Penumbra Inc同比增速更快（22.1% vs 8.5%），过去两年Penumbra Inc的营收复合增速更高（17.6% vs 5.4%）
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
Regency Centers是总部位于美国佛罗里达州杰克逊维尔的房地产投资信托基金，也是以超市为核心租户的大型购物中心运营商之一。截至2020年10月21日，公司共持有415处物业，总建筑面积达5600万平方英尺，知名资产包括Serramonte Center及Village District 30%的股权。
PEN vs REG — 直观对比
营收规模更大
REG
是对方的1.0倍
$385.4M
营收增速更快
PEN
高出13.6%
8.5%
净利率更高
REG
高出37.8%
12.3%
两年增速更快
PEN
近两年复合增速
5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $385.4M | $404.2M |
| 净利润 | $47.3M | $202.5M |
| 毛利率 | 68.0% | — |
| 营业利润率 | 15.4% | 71.0% |
| 净利率 | 12.3% | 50.1% |
| 营收同比 | 22.1% | 8.5% |
| 净利润同比 | 40.6% | 134.1% |
| 每股收益（稀释后） | $1.20 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PENREG
| Q4 25 | $385.4M | $404.2M | ||
| Q3 25 | $354.7M | $387.6M | ||
| Q2 25 | $339.5M | $380.8M | ||
| Q1 25 | $324.1M | $380.9M | ||
| Q4 24 | $315.5M | $372.5M | ||
| Q3 24 | $301.0M | $360.3M | ||
| Q2 24 | $299.4M | $357.3M | ||
| Q1 24 | $278.7M | $363.9M |
净利润PENREG
| Q4 25 | $47.3M | $202.5M | ||
| Q3 25 | $45.9M | $109.4M | ||
| Q2 25 | $45.3M | $106.0M | ||
| Q1 25 | $39.2M | $109.6M | ||
| Q4 24 | $33.7M | $86.5M | ||
| Q3 24 | $29.5M | $101.5M | ||
| Q2 24 | $-60.2M | $102.7M | ||
| Q1 24 | $11.0M | $109.8M |
毛利率PENREG
| Q4 25 | 68.0% | — | ||
| Q3 25 | 67.8% | — | ||
| Q2 25 | 66.0% | — | ||
| Q1 25 | 66.6% | — | ||
| Q4 24 | 66.8% | — | ||
| Q3 24 | 66.5% | — | ||
| Q2 24 | 54.4% | — | ||
| Q1 24 | 65.0% | — |
营业利润率PENREG
| Q4 25 | 15.4% | 71.0% | ||
| Q3 25 | 13.8% | 72.7% | ||
| Q2 25 | 12.0% | 73.8% | ||
| Q1 25 | 12.4% | 71.8% | ||
| Q4 24 | 13.6% | 71.1% | ||
| Q3 24 | 11.7% | 72.5% | ||
| Q2 24 | -27.0% | 72.3% | ||
| Q1 24 | 4.3% | 72.3% |
净利率PENREG
| Q4 25 | 12.3% | 50.1% | ||
| Q3 25 | 12.9% | 28.2% | ||
| Q2 25 | 13.3% | 27.8% | ||
| Q1 25 | 12.1% | 28.8% | ||
| Q4 24 | 10.7% | 23.2% | ||
| Q3 24 | 9.8% | 28.2% | ||
| Q2 24 | -20.1% | 28.7% | ||
| Q1 24 | 3.9% | 30.2% |
每股收益（稀释后）PENREG
| Q4 25 | $1.20 | — | ||
| Q3 25 | $1.17 | — | ||
| Q2 25 | $1.15 | — | ||
| Q1 25 | $1.00 | — | ||
| Q4 24 | $0.88 | — | ||
| Q3 24 | $0.75 | — | ||
| Q2 24 | $-1.55 | — | ||
| Q1 24 | $0.28 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | — |
| 总债务越低越好 | — | $4.7B |
| 股东权益账面价值 | $1.4B | $6.9B |
| 总资产 | $1.8B | $13.0B |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资PENREG
| Q4 25 | $186.9M | — | ||
| Q3 25 | $321.0M | — | ||
| Q2 25 | $421.8M | — | ||
| Q1 25 | $376.1M | — | ||
| Q4 24 | $324.4M | — | ||
| Q3 24 | $280.5M | — | ||
| Q2 24 | $288.3M | — | ||
| Q1 24 | $223.1M | — |
总债务PENREG
| Q4 25 | — | $4.7B | ||
| Q3 25 | — | $4.9B | ||
| Q2 25 | — | $4.8B | ||
| Q1 25 | — | $4.6B | ||
| Q4 24 | — | $4.4B | ||
| Q3 24 | — | $4.4B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $4.4B |
股东权益PENREG
| Q4 25 | $1.4B | $6.9B | ||
| Q3 25 | $1.4B | $6.8B | ||
| Q2 25 | $1.3B | $6.7B | ||
| Q1 25 | $1.2B | $6.7B | ||
| Q4 24 | $1.2B | $6.7B | ||
| Q3 24 | $1.1B | $6.8B | ||
| Q2 24 | $1.2B | $6.8B | ||
| Q1 24 | $1.2B | $7.0B |
总资产PENREG
| Q4 25 | $1.8B | $13.0B | ||
| Q3 25 | $1.7B | $13.1B | ||
| Q2 25 | $1.7B | $12.7B | ||
| Q1 25 | $1.6B | $12.6B | ||
| Q4 24 | $1.5B | $12.4B | ||
| Q3 24 | $1.5B | $12.4B | ||
| Q2 24 | $1.5B | $12.4B | ||
| Q1 24 | $1.6B | $12.7B |
负债/权益比PENREG
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | 0.65× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $86.5M | $203.9M |
| 自由现金流经营现金流 - 资本支出 | $68.0M | — |
| 自由现金流率自由现金流/营收 | 17.7% | — |
| 资本支出强度资本支出/营收 | 4.8% | — |
| 现金转化率经营现金流/净利润 | 1.83× | 1.01× |
| 过去12个月自由现金流最近4个季度 | $174.9M | — |
8季度趋势，按日历期对齐
经营现金流PENREG
| Q4 25 | $86.5M | $203.9M | ||
| Q3 25 | $58.3M | $218.7M | ||
| Q2 25 | $44.9M | $244.0M | ||
| Q1 25 | $49.0M | $161.0M | ||
| Q4 24 | $51.1M | $191.4M | ||
| Q3 24 | $56.5M | $227.6M | ||
| Q2 24 | $22.6M | $203.5M | ||
| Q1 24 | $38.3M | $167.8M |
自由现金流PENREG
| Q4 25 | $68.0M | — | ||
| Q3 25 | $42.0M | — | ||
| Q2 25 | $29.4M | — | ||
| Q1 25 | $35.5M | — | ||
| Q4 24 | $45.7M | — | ||
| Q3 24 | $51.0M | — | ||
| Q2 24 | $18.1M | — | ||
| Q1 24 | $32.5M | — |
自由现金流率PENREG
| Q4 25 | 17.7% | — | ||
| Q3 25 | 11.8% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 16.9% | — | ||
| Q2 24 | 6.0% | — | ||
| Q1 24 | 11.7% | — |
资本支出强度PENREG
| Q4 25 | 4.8% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 2.1% | — |
现金转化率PENREG
| Q4 25 | 1.83× | 1.01× | ||
| Q3 25 | 1.27× | 2.00× | ||
| Q2 25 | 0.99× | 2.30× | ||
| Q1 25 | 1.25× | 1.47× | ||
| Q4 24 | 1.52× | 2.21× | ||
| Q3 24 | 1.91× | 2.24× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | 3.48× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
REG
| Shopping Centers | $418.0M | 103% |
| Propertymanagementservices | $4.1M | 1% |
| Assetmanagementservices | $1.7M | 0% |
